The Latest Breaking News from Vaccine

The U.S. Food and Drug Administration (FDA) has granted fast track designation for the development of TRACON’s (NASDAQ:TCON) lead asset envafolimab (KN035) for patients with locally advanced, unresectable or metastatic undifferentiated pleomorphic sarcoma (UPS) and myxofibrosarcoma (MFS) who have progressed on one or two prior lines of chemotherapy. TRACON shares…

A vaccine candidate, called R21, has been shown to be up to 80% effective at preventing malaria in young children, according to the latest trial results.

TikTik said it did 'not allow harmful misinformation, including medical misinformation, and we will remove it from the platform'

COVID-19 hospitalizations and deaths are down, but White House argues that pandemic money is needed for future public health threats.

The spherical vesicles, which can be delivered to immune cells, are expected to potentially trigger an immune response 

26 million people will be eligible for the coronavirus booster jab this winter, with the elderly and some frontline workers first in the queue to get protected.

The omicron-specific booster vaccine hit the market — some wonder if it's worth getting

A U.S. firm that monitors false online claims reports that searches for information about prominent news topics on TikTok are likely to turn up results riddled with misinformation

HONG KONG: Health authorities will tighten rules on issuing travellers provisional vaccine passes to enter most premises in a bid to plug any loopholes in Hong Kong's policies to combat the coronavirus, the Post has learned.

Last month, the FDA authorized omicron-specific vaccines, accompanied by breathless science-by-press release and a media blitz. Just days after the FDA’s move, the Centers for Disease Control and Prevention followed, recommending updated boosters for anyone age 12 and up who had received at least two doses of the original COVID-19…

SINGAPORE: Singapore on Wednesday granted interim authorisation for a bivalent Covid-19 booster vaccine made by Moderna, the government said in a statement.